Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311146593> ?p ?o ?g. }
Showing items 1 to 64 of
64
with 100 items per page.
- W4311146593 endingPage "100250" @default.
- W4311146593 startingPage "100250" @default.
- W4311146593 abstract "Interim analysis of the open-label phase 3 RATIONALE-304 study (NCT03663205) demonstrated clinical benefit of tislelizumab (TIS) plus chemotherapy (chemo) as first-line (1L) therapy in patients with advanced nsq-NSCLC vs chemo alone, with significantly improved progression-free survival (PFS) and a manageable safety profile. Here, we report the updated results." @default.
- W4311146593 created "2022-12-23" @default.
- W4311146593 creator A5006891854 @default.
- W4311146593 creator A5031855342 @default.
- W4311146593 creator A5047770529 @default.
- W4311146593 creator A5049966746 @default.
- W4311146593 creator A5065019811 @default.
- W4311146593 creator A5069488345 @default.
- W4311146593 creator A5078265673 @default.
- W4311146593 creator A5085012170 @default.
- W4311146593 creator A5085765278 @default.
- W4311146593 creator A5087762081 @default.
- W4311146593 date "2022-12-01" @default.
- W4311146593 modified "2023-09-27" @default.
- W4311146593 title "138P Randomized phase III study of tislelizumab plus chemotherapy versus chemotherapy alone as first-line treatment for advanced non-squamous non-small cell lung cancer (nsq-NSCLC): RATIONALE-304 updated analysis" @default.
- W4311146593 doi "https://doi.org/10.1016/j.iotech.2022.100250" @default.
- W4311146593 hasPublicationYear "2022" @default.
- W4311146593 type Work @default.
- W4311146593 citedByCount "0" @default.
- W4311146593 crossrefType "journal-article" @default.
- W4311146593 hasAuthorship W4311146593A5006891854 @default.
- W4311146593 hasAuthorship W4311146593A5031855342 @default.
- W4311146593 hasAuthorship W4311146593A5047770529 @default.
- W4311146593 hasAuthorship W4311146593A5049966746 @default.
- W4311146593 hasAuthorship W4311146593A5065019811 @default.
- W4311146593 hasAuthorship W4311146593A5069488345 @default.
- W4311146593 hasAuthorship W4311146593A5078265673 @default.
- W4311146593 hasAuthorship W4311146593A5085012170 @default.
- W4311146593 hasAuthorship W4311146593A5085765278 @default.
- W4311146593 hasAuthorship W4311146593A5087762081 @default.
- W4311146593 hasBestOaLocation W43111465931 @default.
- W4311146593 hasConcept C126322002 @default.
- W4311146593 hasConcept C143998085 @default.
- W4311146593 hasConcept C2776256026 @default.
- W4311146593 hasConcept C2776694085 @default.
- W4311146593 hasConcept C2779177807 @default.
- W4311146593 hasConcept C71924100 @default.
- W4311146593 hasConcept C81729549 @default.
- W4311146593 hasConceptScore W4311146593C126322002 @default.
- W4311146593 hasConceptScore W4311146593C143998085 @default.
- W4311146593 hasConceptScore W4311146593C2776256026 @default.
- W4311146593 hasConceptScore W4311146593C2776694085 @default.
- W4311146593 hasConceptScore W4311146593C2779177807 @default.
- W4311146593 hasConceptScore W4311146593C71924100 @default.
- W4311146593 hasConceptScore W4311146593C81729549 @default.
- W4311146593 hasLocation W43111465931 @default.
- W4311146593 hasOpenAccess W4311146593 @default.
- W4311146593 hasPrimaryLocation W43111465931 @default.
- W4311146593 hasRelatedWork W2039727128 @default.
- W4311146593 hasRelatedWork W2053740948 @default.
- W4311146593 hasRelatedWork W2348529436 @default.
- W4311146593 hasRelatedWork W2358450743 @default.
- W4311146593 hasRelatedWork W2381460883 @default.
- W4311146593 hasRelatedWork W2413020017 @default.
- W4311146593 hasRelatedWork W2480785262 @default.
- W4311146593 hasRelatedWork W2589143814 @default.
- W4311146593 hasRelatedWork W3031381806 @default.
- W4311146593 hasRelatedWork W3032349186 @default.
- W4311146593 hasVolume "16" @default.
- W4311146593 isParatext "false" @default.
- W4311146593 isRetracted "false" @default.
- W4311146593 workType "article" @default.